Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000002767 | SCV000791297 | likely pathogenic | Neuronal ceroid lipofuscinosis 2 | 2017-05-15 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001851588 | SCV002128614 | pathogenic | not provided | 2023-08-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects TPP1 function (PMID: 14736728, 15317752, 20340139). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TPP1 protein function. ClinVar contains an entry for this variant (Variation ID: 2648). This missense change has been observed in individual(s) with neuronal ceroid lipofuscinosis (PMID: 12376936, 30541466). This variant is present in population databases (rs119455958, gnomAD 0.0009%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 286 of the TPP1 protein (p.Asn286Ser). |
OMIM | RCV000002767 | SCV000022925 | pathogenic | Neuronal ceroid lipofuscinosis 2 | 2004-04-01 | no assertion criteria provided | literature only | |
Uni |
RCV000002767 | SCV000091201 | not provided | Neuronal ceroid lipofuscinosis 2 | no assertion provided | not provided |